Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

positiveEmperor Total Artificial HeartPositive

AI Analysis

Summary

Picard Medical and SynCardia reported successful preclinical implant studies for the next-generation Emperor Total Artificial Heart, demonstrating stable full circulatory support with a dual motor ventricular design.

Outcome Details

Successful preclinical implant studies with dual motor ventricular design demonstrating stable full circulatory support

Importance:5/10

Sentiment:

0.70

preclinicalmedical deviceartificial heartcardiovascular

Related Companies

$MDCE $DSGN

Read the original article

Published by GlobeNewswire Clinical Studies on June 2, 2026 11:00 AM

Read Original